Evidence map›Paper›PMID 28993995›Full record

ArticleNeurochemical research2017

PI3K/Akt and ERK/MAPK Signaling Promote Different Aspects of Neuron Survival and Axonal Regrowth Following Rat Facial Nerve Axotomy.

Haitao Huang, Huawei Liu, Rongzeng Yan, Min Hu

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Novel affibody molecules targeting the AXL extracellular structural domain for molecular imaging and targeted therapy of gastric cancer.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2025
    Article
  13. Review
  14. Review
  15. Review
  16. GFRα1 Promotes Axon Regeneration after Peripheral Nerve Injury by Functioning as a Ligand.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Haitao HuangDepartment of Stomatology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China.
Huawei LiuDepartment of Stomatology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China.
Rongzeng YanDepartment of Stomatology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China.
Min HuDepartment of Stomatology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China. humin48@vip.163.com.
Chinese PLA General Hospital · CNSecond Affiliated Hospital of Dalian Medical University · CN

Funding

Beijing Municipal Natural Science Foundation 7132173National Natural Science Foundation of China 30872898
6 · The paper itself

Abstract

The ERK/MAPK and PI3K/Akt signaling pathways play important role in neuronal survival and axonal regeneration after peripheral nerve injury. However, the relative importance and degree of functional overlap of the two pathways are still debated due to lack of in-vivo data. We used rats which underwent a facial nerve axotomy, and examined subsequent ERK/MAPK and PI3K/Akt signaling activity by quantifying phosphorylation of ERK and Akt. We also assessed the survival rate of facial neurons, number of regenerated axons, and the length of axonal regrowth in axotomized animals treated with an inhibitor of ERK/MAPK (U0126) or PI3K/Akt (LY294002) phosphorylation, or with vehicle. Axotomy increased phosphorylation of ERK and Akt in the facial nucleus 7 days after injury. The inhibition of ERK phosphorylation significantly reduced the length of regenerated axons, but not the other parameters. Inhibition of Akt phosphorylation significantly reduced the survival rate of facial neurons and the number of new axons, as well as the length of regenerated axons. The results indicate that facial nerve injury activates the ERK/MAPK and PI3K/Akt signaling pathways in the facial nerve nucleus and its axons. However, the pathways promoted aspects of regeneration with only slight overlap: PI3K/Akt signaling improved the survival of neurons, as well as axonal growth and branching, whereas ERK/MAPK signaling promoted only axonal extension.

Indexed as

AxotomyAnimalsAxonsButadienesCell SurvivalFacial NerveMaleMitogen-Activated Protein KinasesNerve RegenerationNitrilesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRats, Sprague-DawleyRetinal Ganglion CellsButadienesMitogen-Activated Protein KinasesNitrilesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktU 0126Axonal regenerationCranial nerve sevenKinaseNeurite extensionNeuron survival

Identifiers

PMID28993995
OpenAlexW2761722016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.